Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Genomics Analysis of L-DOPA Exposure in Drosophila sechellia.

Lanno SM, Lam I, Drum Z, Linde SC, Gregory SM, Shimshak SJ, Becker MV, Brew KE, Budhiraja A, Carter EA, Chigweshe L, Collins KP, Earley T, Einstein HL, Fan AA, Goss SS, Hagen ER, Hutcheon SB, Kim TT, Mitchell MA, Neri NR, Patterson SE, Ransom G, Sanchez GJ, Weiner BM, Zhao D, Coolon JD.

G3 (Bethesda). 2019 Oct 1. pii: g3.400552.2019. doi: 10.1534/g3.119.400552. [Epub ahead of print]

2.

Distinct dual antiviral mechanism that enhances hepatitis B virus mutagenesis and reduces viral DNA synthesis.

McDaniel YZ, Patterson SE, Mansky LM.

Antiviral Res. 2019 Oct;170:104540. doi: 10.1016/j.antiviral.2019.104540. Epub 2019 Jun 25.

PMID:
31247245
3.

Re-evaluation of the ethylene-dependent and -independent pathways in the regulation of floral and organ abscission.

Meir S, Philosoph-Hadas S, Riov J, Tucker ML, Patterson SE, Roberts JA.

J Exp Bot. 2019 Mar 11;70(5):1461-1467. doi: 10.1093/jxb/erz038.

PMID:
30726930
4.

Utility of the JAX Clinical Knowledgebase in capture and assessment of complex genomic cancer data.

Patterson SE, Statz CM, Yin T, Mockus SM.

NPJ Precis Oncol. 2019 Jan 15;3:2. doi: 10.1038/s41698-018-0073-y. eCollection 2019.

5.

GENDER AND THE MBA: Differences in Career Trajectories, Institutional Support, and Outcomes.

Patterson SE, Damaske S, Sheroff C.

Gend Soc. 2017 Jun;31(3):310-332. doi: 10.1177/0891243217703630. Epub 2017 Apr 10.

6.

Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis.

Qiu L, Patterson SE, Bonnac LF, Geraghty RJ.

PLoS Negl Trop Dis. 2018 Apr 19;12(4):e0006421. doi: 10.1371/journal.pntd.0006421. eCollection 2018 Apr.

7.

An Official American Thoracic Society Workshop Report: Chemical Inhalational Disasters. Biology of Lung Injury, Development of Novel Therapeutics, and Medical Preparedness.

Summerhill EM, Hoyle GW, Jordt SE, Jugg BJ, Martin JG, Matalon S, Patterson SE, Prezant DJ, Sciuto AM, Svendsen ER, White CW, Veress LA; ATS Terrorism and Inhalational Disasters Section of the Environmental, Occupational, and Population Health Assembly.

Ann Am Thorac Soc. 2017 Jun;14(6):1060-1072. doi: 10.1513/AnnalsATS.201704-297WS.

8.

In-vitro mercaptopyruvate sulfurtransferase species comparison in humans and common laboratory animals.

Moeller BM, Crankshaw DL, Briggs J, Nagasawa HT, Patterson SE.

Toxicol Lett. 2017 May 15;274:64-68. doi: 10.1016/j.toxlet.2017.04.005. Epub 2017 Apr 12.

9.

Barriers preventing the adoption of comprehensive cancer genomic profiling in the clinic.

Statz CM, Patterson SE, Mockus SM.

Expert Rev Mol Diagn. 2017 Jun;17(6):549-555. doi: 10.1080/14737159.2017.1319280. Epub 2017 Apr 18. Review.

PMID:
28402162
10.

Single-parent households and mortality among children and youth.

Amato PR, Patterson SE.

Soc Sci Res. 2017 Mar;63:253-262. doi: 10.1016/j.ssresearch.2016.09.017. Epub 2016 Sep 29.

PMID:
28202147
11.

Assessing Spatial and Temporal Differences in State-Level Child Well-Being Based on Tests of Statistical Significance.

Patterson SE, O'Hare WP.

Child Indic Res. 2016 Dec;9(4):1077-1093. doi: 10.1007/s12187-015-9354-y. Epub 2015 Dec 9.

12.

mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic Review.

Statz CM, Patterson SE, Mockus SM.

Target Oncol. 2017 Feb;12(1):47-59. doi: 10.1007/s11523-016-0453-6. Review.

PMID:
27503005
13.

Development of sulfanegen for mass cyanide casualties.

Patterson SE, Moeller B, Nagasawa HT, Vince R, Crankshaw DL, Briggs J, Stutelberg MW, Vinnakota CV, Logue BA.

Ann N Y Acad Sci. 2016 Jun;1374(1):202-9. doi: 10.1111/nyas.13114. Epub 2016 Jun 16. Review.

14.

Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase.

Rawson JM, Roth ME, Xie J, Daly MB, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM.

Bioorg Med Chem. 2016 Jun 1;24(11):2410-22. doi: 10.1016/j.bmc.2016.03.052. Epub 2016 Mar 30.

PMID:
27117260
15.

Dual anti-HIV mechanism of clofarabine.

Daly MB, Roth ME, Bonnac L, Maldonado JO, Xie J, Clouser CL, Patterson SE, Kim B, Mansky LM.

Retrovirology. 2016 Mar 24;13:20. doi: 10.1186/s12977-016-0254-0.

16.

Are We on the Right Track: Can Our Understanding of Abscission in Model Systems Promote or Derail Making Improvements in Less Studied Crops?

Patterson SE, Bolivar-Medina JL, Falbel TG, Hedtcke JL, Nevarez-McBride D, Maule AF, Zalapa JE.

Front Plant Sci. 2016 Jan 26;6:1268. doi: 10.3389/fpls.2015.01268. eCollection 2015.

17.

5-Azacytidine Enhances the Mutagenesis of HIV-1 by Reduction to 5-Aza-2'-Deoxycytidine.

Rawson JM, Daly MB, Xie J, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2318-25. doi: 10.1128/AAC.03084-15. Print 2016 Apr.

18.

Molecular Genetic Analysis of Ovarian Brenner Tumors and Associated Mucinous Epithelial Neoplasms: High Variant Concordance and Identification of Mutually Exclusive RAS Driver Mutations and MYC Amplification.

Tafe LJ, Muller KE, Ananda G, Mitchell T, Spotlow V, Patterson SE, Tsongalis GJ, Mockus SM.

Am J Pathol. 2016 Mar;186(3):671-7. doi: 10.1016/j.ajpath.2015.11.008. Epub 2016 Jan 18.

19.

The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies.

Patterson SE, Liu R, Statz CM, Durkin D, Lakshminarayana A, Mockus SM.

Hum Genomics. 2016 Jan 16;10:4. doi: 10.1186/s40246-016-0061-7.

20.

The impact of criminalization of HIV non-disclosure on the healthcare engagement of women living with HIV in Canada: a comprehensive review of the evidence.

Patterson SE, Milloy MJ, Ogilvie G, Greene S, Nicholson V, Vonn M, Hogg R, Kaida A.

J Int AIDS Soc. 2015 Dec 22;18:20572. doi: 10.7448/IAS.18.1.20572. eCollection 2015. Review.

21.

Simultaneous determination of 3-mercaptopyruvate and cobinamide in plasma by liquid chromatography-tandem mass spectrometry.

Stutelberg MW, Dzisam JK, Monteil AR, Petrikovics I, Boss GR, Patterson SE, Rockwood GA, Logue BA.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jan 1;1008:181-188. doi: 10.1016/j.jchromb.2015.11.027. Epub 2015 Nov 21.

PMID:
26655110
22.

Clinical Trials in Precision Oncology.

Mockus SM, Patterson SE, Statz C, Bult CJ, Tsongalis GJ.

Clin Chem. 2016 Mar;62(3):442-8. doi: 10.1373/clinchem.2015.247437. Epub 2015 Nov 25. Review.

23.

Lack of mutational hot spots during decitabine-mediated HIV-1 mutagenesis.

Rawson JM, Landman SR, Reilly CS, Bonnac L, Patterson SE, Mansky LM.

Antimicrob Agents Chemother. 2015 Nov;59(11):6834-43. doi: 10.1128/AAC.01644-15. Epub 2015 Aug 17.

24.

Novel inhibitors of human immunodeficiency virus type 2 infectivity.

Beach LB, Rawson JM, Kim B, Patterson SE, Mansky LM.

J Gen Virol. 2014 Dec;95(Pt 12):2778-83. doi: 10.1099/vir.0.069864-0. Epub 2014 Aug 7.

25.

Assessment of the sensitivity of three North American fish species to disruptors of steroidogenesis using in vitro tissue explants.

Beitel SC, Doering JA, Patterson SE, Hecker M.

Aquat Toxicol. 2014 Jul;152:273-83. doi: 10.1016/j.aquatox.2014.04.013. Epub 2014 Apr 19.

PMID:
24800870
26.

Noninvasive optical cytochrome c oxidase redox state measurements using diffuse optical spectroscopy.

Lee J, Kim JG, Mahon SB, Mukai D, Yoon D, Boss GR, Patterson SE, Rockwood G, Isom G, Brenner M.

J Biomed Opt. 2014 May;19(5):055001. doi: 10.1117/1.JBO.19.5.055001.

27.

Mechanisms and models of endoplasmic reticulum stress in chondrodysplasia.

Patterson SE, Dealy CN.

Dev Dyn. 2014 Jul;243(7):875-93. doi: 10.1002/dvdy.24131. Epub 2014 Apr 16. Review.

28.

Cell surface ABP1-TMK auxin-sensing complex activates ROP GTPase signaling.

Xu T, Dai N, Chen J, Nagawa S, Cao M, Li H, Zhou Z, Chen X, De Rycke R, Rakusov√° H, Wang W, Jones AM, Friml J, Patterson SE, Bleecker AB, Yang Z.

Science. 2014 Feb 28;343(6174):1025-8. doi: 10.1126/science.1245125.

29.

Determination of 3-mercaptopyruvate in rabbit plasma by high performance liquid chromatography tandem mass spectrometry.

Stutelberg MW, Vinnakota CV, Mitchell BL, Monteil AR, Patterson SE, Logue BA.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Feb 15;949-950:94-8. doi: 10.1016/j.jchromb.2014.01.006. Epub 2014 Jan 18.

30.

Discovery of novel ribonucleoside analogs with activity against human immunodeficiency virus type 1.

Dapp MJ, Bonnac L, Patterson SE, Mansky LM.

J Virol. 2014 Jan;88(1):354-63. doi: 10.1128/JVI.02444-13. Epub 2013 Oct 23.

31.

5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors.

Rawson JM, Heineman RH, Beach LB, Martin JL, Schnettler EK, Dapp MJ, Patterson SE, Mansky LM.

Bioorg Med Chem. 2013 Nov 15;21(22):7222-8. doi: 10.1016/j.bmc.2013.08.023. Epub 2013 Aug 20.

32.

Analysis of gene expression during the transition to climacteric phase in carnation flowers (Dianthus caryophyllus L.).

In BC, Binder BM, Falbel TG, Patterson SE.

J Exp Bot. 2013 Nov;64(16):4923-37. doi: 10.1093/jxb/ert281. Epub 2013 Sep 28.

33.

Characterization of permeability, stability and anti-HIV-1 activity of decitabine and gemcitabine divalerate prodrugs.

Clouser CL, Bonnac L, Mansky LM, Patterson SE.

Antivir Chem Chemother. 2014 Dec 16;23(6):223-30. doi: 10.3851/IMP2682.

34.

NEVERSHED and INFLORESCENCE DEFICIENT IN ABSCISSION are differentially required for cell expansion and cell separation during floral organ abscission in Arabidopsis thaliana.

Liu B, Butenko MA, Shi CL, Bolivar JL, Winge P, Stenvik GE, Vie AK, Leslie ME, Brembu T, Kristiansen W, Bones AM, Patterson SE, Liljegren SJ, Aalen RB.

J Exp Bot. 2013 Dec;64(17):5345-57. doi: 10.1093/jxb/ert232. Epub 2013 Aug 20.

PMID:
23963677
35.

Structure-activity relationships and design of viral mutagens and application to lethal mutagenesis.

Bonnac LF, Mansky LM, Patterson SE.

J Med Chem. 2013 Dec 12;56(23):9403-14. doi: 10.1021/jm400653j. Epub 2013 Aug 26. Review.

PMID:
23914828
36.

The TMK subfamily of receptor-like kinases in Arabidopsis display an essential role in growth and a reduced sensitivity to auxin.

Dai N, Wang W, Patterson SE, Bleecker AB.

PLoS One. 2013 Apr 16;8(4):e60990. doi: 10.1371/journal.pone.0060990. Print 2013.

37.

New clothes for the jasmonic acid receptor COI1: delayed abscission, meristem arrest and apical dominance.

Kim J, Dotson B, Rey C, Lindsey J, Bleecker AB, Binder BM, Patterson SE.

PLoS One. 2013;8(4):e60505. doi: 10.1371/journal.pone.0060505. Epub 2013 Apr 1. Erratum in: PLoS One. 2015;10(3):e0119063.

38.

Cyanide antidotes for mass casualties: water-soluble salts of the dithiane (sulfanegen) from 3-mercaptopyruvate for intramuscular administration.

Patterson SE, Monteil AR, Cohen JF, Crankshaw DL, Vince R, Nagasawa HT.

J Med Chem. 2013 Feb 14;56(3):1346-9. doi: 10.1021/jm301633x. Epub 2013 Jan 30.

39.

Noninvasive monitoring of treatment response in a rabbit cyanide toxicity model reveals differences in brain and muscle metabolism.

Kim JG, Lee J, Mahon SB, Mukai D, Patterson SE, Boss GR, Tromberg BJ, Brenner M.

J Biomed Opt. 2012 Oct;17(10):105005. doi: 10.1117/1.JBO.17.10.105005.

40.

Reducing jasmonic acid levels causes ein2 mutants to become ethylene responsive.

Kim J, Patterson SE, Binder BM.

FEBS Lett. 2013 Jan 16;587(2):226-30. doi: 10.1016/j.febslet.2012.11.030. Epub 2012 Dec 7.

41.

Fss/Tbx6 is required for central dermomyotome cell fate in zebrafish.

Windner SE, Bird NC, Patterson SE, Doris RA, Devoto SH.

Biol Open. 2012 Aug 15;1(8):806-14. doi: 10.1242/bio.20121958. Epub 2012 Jun 29.

42.

Back to the future: revisiting HIV-1 lethal mutagenesis.

Dapp MJ, Patterson SE, Mansky LM.

Trends Microbiol. 2013 Feb;21(2):56-62. doi: 10.1016/j.tim.2012.10.006. Epub 2012 Nov 27.

43.

Seasonal pasture myopathy/atypical myopathy in North America associated with ingestion of hypoglycin A within seeds of the box elder tree.

Valberg SJ, Sponseller BT, Hegeman AD, Earing J, Bender JB, Martinson KL, Patterson SE, Sweetman L.

Equine Vet J. 2013 Jul;45(4):419-26. doi: 10.1111/j.2042-3306.2012.00684.x. Epub 2012 Nov 20.

PMID:
23167695
44.

IP-FCM measures physiologic protein-protein interactions modulated by signal transduction and small-molecule drug inhibition.

Smith SE, Bida AT, Davis TR, Sicotte H, Patterson SE, Gil D, Schrum AG.

PLoS One. 2012;7(9):e45722. doi: 10.1371/journal.pone.0045722. Epub 2012 Sep 21.

45.

Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine.

Clouser CL, Chauhan J, Bess MA, van Oploo JL, Zhou D, Dimick-Gray S, Mansky LM, Patterson SE.

Bioorg Med Chem Lett. 2012 Nov 1;22(21):6642-6. doi: 10.1016/j.bmcl.2012.08.108. Epub 2012 Sep 6.

46.

Cyanide toxicity in juvenile pigs and its reversal by a new prodrug, sulfanegen sodium.

Belani KG, Singh H, Beebe DS, George P, Patterson SE, Nagasawa HT, Vince R.

Anesth Analg. 2012 May;114(5):956-61. doi: 10.1213/ANE.0b013e31824c4eb5. Epub 2012 Mar 5.

47.

Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1.

Clouser CL, Holtz CM, Mullett M, Crankshaw DL, Briggs JE, O'Sullivan MG, Patterson SE, Mansky LM.

Antimicrob Agents Chemother. 2012 Apr;56(4):1942-8. doi: 10.1128/AAC.06161-11. Epub 2012 Jan 23.

48.

Discovery of drugs that possess activity against feline leukemia virus.

Greggs WM 3rd, Clouser CL, Patterson SE, Mansky LM.

J Gen Virol. 2012 Apr;93(Pt 4):900-5. doi: 10.1099/vir.0.039909-0. Epub 2012 Jan 18.

49.

The combination of cobinamide and sulfanegen is highly effective in mouse models of cyanide poisoning.

Chan A, Crankshaw DL, Monteil A, Patterson SE, Nagasawa HT, Briggs JE, Kozocas JA, Mahon SB, Brenner M, Pilz RB, Bigby TD, Boss GR.

Clin Toxicol (Phila). 2011 Jun;49(5):366-73. doi: 10.3109/15563650.2011.584879.

50.

Broadening the use of antiretroviral therapy: the case for feline leukemia virus.

Greggs WM 3rd, Clouser CL, Patterson SE, Mansky LM.

Ther Clin Risk Manag. 2011;7:115-22. doi: 10.2147/TCRM.S17731. Epub 2011 Mar 16.

Supplemental Content

Loading ...
Support Center